These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 11989900)

  • 1. Medical treatment of colorectal cancer in elderly (>70 years): GISCAD experience and future perspectives. Italian Group for the Study of Digestive Tract Cancer.
    Beretta GD; Ferrari VD; Barni S; Pancera G; Labianca R
    Tumori; 2002; 88(1 Suppl 1):S109-12. PubMed ID: 11989900
    [No Abstract]   [Full Text] [Related]  

  • 2. Indications and feasibility of adjuvant chemotherapy in elderly patients with colorectal cancer.
    Aschele C; Sartor L; Lonardi S
    Tumori; 2002; 88(1 Suppl 1):S113-4. PubMed ID: 11989901
    [No Abstract]   [Full Text] [Related]  

  • 3. Repetita iuvant--INTACC (Intergruppo Italiano Terapia Adiuvante Carcinoma Del Colon).
    Di Costanzo D; Gasperoni S; Dogliotti AL; Frassinetti L; Bruzzi P; Rosso R
    Ann Oncol; 2001 Sep; 12(9):1331. PubMed ID: 11697849
    [No Abstract]   [Full Text] [Related]  

  • 4. Elderly patients with advanced colorectal cancer: which therapy is the safest?
    Rosati G
    Expert Opin Drug Saf; 2005 Nov; 4(6):1041-9. PubMed ID: 16255663
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Oxaliplatin- or irinotecan-based chemotherapy for metastatic colorectal cancer in the elderly.
    Alliot C; Barrios M
    Br J Cancer; 2004 May; 90(10):2050-1; author reply 2051-2. PubMed ID: 15138493
    [No Abstract]   [Full Text] [Related]  

  • 6. [Irinotecan plus fluorouracil and folinic acid in metastatic colorectal cancer].
    Krieger G
    Strahlenther Onkol; 2001 Jun; 177(6):316-8. PubMed ID: 11446323
    [No Abstract]   [Full Text] [Related]  

  • 7. [Capecitabine and irinotecan].
    Gasperoni S
    Suppl Tumori; 2004; 3(4):S107-8. PubMed ID: 15206231
    [No Abstract]   [Full Text] [Related]  

  • 8. Raltitrexed plus oxaliplatin (TOMOX) as first-line chemotherapy for metastatic colorectal cancer. A phase II study of the Italian Group for the Study of Gastrointestinal Tract Carcinomas (GISCAD).
    Cascinu S; Graziano F; Ferraù F; Catalano V; Massacesi C; Santini D; Silva RR; Barni S; Zaniboni A; Battelli N; Siena S; Giordani P; Mari D; Baldelli AM; Antognoli S; Maisano R; Priolo D; Pessi MA; Tonini G; Rota S; Labianca R
    Ann Oncol; 2002 May; 13(5):716-20. PubMed ID: 12075739
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Do we need oncology trials tailored for the elderly or frail?
    Schmoll HJ
    Lancet; 2011 May; 377(9779):1725-7. PubMed ID: 21601694
    [No Abstract]   [Full Text] [Related]  

  • 10. Do all patients with metastatic colorectal cancer need chemotherapy until disease progression?
    Gibson TB; Grothey A
    Clin Colorectal Cancer; 2006 Sep; 6(3):196-201. PubMed ID: 17026788
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MONARCC: a randomised phase II study of panitumumab monotherapy and panitumumab plus 5-fluorouracil as first-line therapy for RAS and BRAF wildtype metastatic colorectal cancer: a study by the Australasian Gastrointestinal Trials Group (AGITG).
    Siu HWD; Tebbutt N; Chantrill L; Karapetis C; Steer C; Wilson K; Espinoza D; Bailey L; Yip S; Cuff J; Pavlakis N; Thavaneswaran S; Briscoe K; Srivastav R; Shannon J; Segelov E; Tie J; Caird S; Francesconi A; Price T; Wuttke M; Ladwa R; Sjoquist K; Burge M
    BMC Cancer; 2021 Aug; 21(1):932. PubMed ID: 34407800
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The value of oxaliplatin in combination with continuous infusion +/- bolus 5-fluorouracil and levo-folinic acid in metastatic colorectal cancer progressing after 5FU-based chemotherapy: a GISCAD (Italian Group for the Study of Digestive Tract) cancer phase II trial.
    Mosconi S; Cascinu S; Zaniboni A; Catalano V; Giordani P; Beretta GD; Martignoni G; Pancera G; Baldelli AM; Poletti P; Curti C; Labianca R
    Tumori; 2000; 86(6):465-9. PubMed ID: 11218187
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Colorectal carcinoma--approval of eloxatine in adjuvant therapy--better chances for recovery].
    Krankenpfl J; 2004; 42(7-10):234. PubMed ID: 15675396
    [No Abstract]   [Full Text] [Related]  

  • 14. Metastatic colorectal cancer: treatment challenges and quality of life.
    Bottomley A
    Lancet; 2002 May; 359(9317):1537-8. PubMed ID: 12047959
    [No Abstract]   [Full Text] [Related]  

  • 15. [Chemotherapy of elderly patients with colorectal cancer].
    Landherr L; Nagykálnai T
    Magy Onkol; 2009 Jun; 53(2):97-105. PubMed ID: 19581175
    [TBL] [Abstract][Full Text] [Related]  

  • 16. TAS-102 in metastatic colorectal cancer.
    Burki TK
    Lancet Oncol; 2018 Jan; 19(1):e18. PubMed ID: 29249306
    [No Abstract]   [Full Text] [Related]  

  • 17. [Therapy of colorectal carcinoma. To combine saves lives].
    Arnheim KE
    MMW Fortschr Med; 2004 Jan; 146(1-2):14. PubMed ID: 18441573
    [No Abstract]   [Full Text] [Related]  

  • 18. Biochemical modulation of fluoropyrimidines: the "GISCAD" studies. GISCAD (Italian Group for the Study of Digestive Tract Cancer).
    Labianca R; Pancera G; Barni S; Cascinu S; Comella G; Foa P; Martignoni G; Zaniboni A; Giaccon G; Luporini G
    Adv Exp Med Biol; 1993; 339():233-7. PubMed ID: 8178720
    [No Abstract]   [Full Text] [Related]  

  • 19. High plasma TIMP-1 and serum CEA levels during combination chemotherapy for metastatic colorectal cancer are significantly associated with poor outcome.
    Aldulaymi B; Byström P; Berglund A; Christensen IJ; Brünner N; Nielsen HJ; Glimelius B
    Oncology; 2010; 79(1-2):144-9. PubMed ID: 21150229
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High-versus low-dose levo-leucovorin as a modulator of 5-fluorouracil in advanced colorectal cancer: a 'GISCAD' phase III study. Italian Group for the Study of Digestive Tract Cancer.
    Labianca R; Cascinu S; Frontini L; Barni S; Fiorentini G; Comella G; Zaniboni A; Gottardi O; Arnoldi E; Oliani C; Duro M; Pavanato G; Martignoni G; Raina A; Piazza E; Dallavalle G; Valsecchi R; Pancera G; Luporini G
    Ann Oncol; 1997 Feb; 8(2):169-74. PubMed ID: 9093726
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.